Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis

Expert Review of Gastroenterology and Hepatology

Volumn 6, Issue 3, 2012, Pages 267-269

  Liberal, Rodrigo ^a,b   Vergani, Diego ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Asians; autoimmune hepatitis; Caucasians; clinical outcome; epidemiology; Hispanics

Indexed keywords

ALBUMIN; HLA DRB1 ANTIGEN;

AGE DISTRIBUTION; ASIAN; AUTOIMMUNE HEPATITIS; CAUCASIAN; CHROMOSOME 6; DISEASE SEVERITY; ETHNICITY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HISPANIC; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MORTALITY; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; REVIEW; SEX RATIO; SURVIVAL; THROMBOCYTE COUNT;

EID: 84861724794     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.12.17     Document Type: Review

References (17)

1. Manns MP, Czaja AJ, Gorham JD et al.; American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis. Hepatology 51(6), 2193-2213 (2010
2. Liberal R, Longhi MS, Mieli-Vergani G, Vergani D. Pathogenesis of autoimmune hepatitis. Best Pract. Res. Clin. Gastroenterol. 25(6), 653-664 (2011
3. Wong RJ, Gish R, Frederick T, Bzowej N, Frenette C. The impact of race/ethnicity on the clinical epidemiology of autoimmune hepatitis. J. Clin. Gastroenterol. 46(2), 155-161 (2012
4. Lim KN, Casanova RL, Boyer TD, Bruno CJ. Autoimmune hepatitis in African Americans: presenting features and response to therapy. Am. J. Gastroenterol. 96(12), 3390-3394 (2001 (Pubitemid 34016665)
5. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology 46(6), 1828-1835 (2007
6. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am. J. Gastroenterol. 97(9), 2402-2407 (2002
7. Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am. J. Gastroenterol. 99(8), 1510-1516 (2004 (Pubitemid 39180099)
8. Verma S, Redeker A. In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow-up associated with a poorer outcome? Hepatology 42(5), 1237; author reply 1237-author reply 1238 (2005 (Pubitemid 43112691)
9. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. Hepatology 42(1), 53-62 (2005 (Pubitemid 40911311)
10. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 110(3), 848-857 (1996 (Pubitemid 26071852)
11. Donaldson PT. Genetics of liver disease: immunogenetics and disease pathogenesis. Gut 53(4), 599-608 (2004 (Pubitemid 38372988)
12. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology 105(5), 1502-1507 (1993 (Pubitemid 23315327)
13. Czaja AJ, Strettell MD, Thomson LJ et al. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. Hepatology 25(2), 317-323 (1997 (Pubitemid 27069049)
14. Donaldson PT. Genetics of autoimmune and viral liver diseases; understanding the issues. J. Hepatol. 41(2), 327-332 (2004 (Pubitemid 39177639)
15. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 13(4), 701-706 1991
16. Strettell MD, Donaldson PT, Thomson LJ et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology 112(6), 2028-2035 (1997 (Pubitemid 27240790)
17. Czaja AJ, Souto EO, Bittencourt PL et al. Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States. J. Hepatol. 37(3), 302-308 (2002) (Pubitemid 34969945)